Recombinant Human Collagen IV alpha 1/Arresten Protein, CF New
Recombinant Human Collagen IV alpha 1/Arresten Protein, CF Summary
Product Specifications
Ser1441-Thr1669, with a C-ter 6xHis tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
11597-CL
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
Reconstitution | Reconstitute at 250 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Scientific Data
Recombinant Human Collagen IV alpha 1 His-tag Protein (Catalog # 11597-CL) binds Recombinant Human Integrin alpha 1 beta 1 (7064-AB) with an ED50 of 85.0‑850 ng/mL.
2 μg/lane of Recombinant Human Collagen IV alpha 1 His-tag Protein (Catalog # 11597-CL) was resolved with SDS-PAGE under reducing (R) condition and visualized by Coomassie® Blue staining, showing bands at 22‑33 kDa.
Reconstitution Calculator
Background: Collagen IV alpha 1
Type IV collagen is a member of the collagen superfamily. Unlike other collagens, type IV occurs only in basement membranes. In mammals, type IV collagen has up to 6 genetically distinct alpha chains, designated alpha-1(IV) to alpha-6(IV), each of which can form a triple helix structure with two other chains (1-3). Each chain contains three domains: a cysteine- and lysine-rich N-terminal domain, a collagenous triple repeat region, and a non-collagenous (NC1) C-terminal domain (4). The cysteine and lysine residues at the amino-terminal domain are essential for interchain crosslinking (5). Arresten, which comprise the C-terminal NC1 domain, has anti-angiogenic activity and inhibits tumor formation (6-7). Within this region, human Arresten shares 97% and 75% sequence identity with mouse and rat Arresten, respectively.
- Myllyharju, J. and KI Kivirikko (2004) Trends Genet. 20:33.
- Veit, G. et al. (2006) J. Biol. Chem. 281:3494.
- Guey, S. and D. Herve (2022) Cereb. Circ. Cogn. Behav. 3:100140.
- Hudson, B.G., et al. (2003) N. Engl. J. Med. 348:2543.
- Than, M.E. et al. (2002) Proc. Natl. Acad. Sci. USA 99:6607.
- Nyberg, P. et al. (2008) Exp. Cell Res. 314:3292.
- Colorado, P.C. et al. (2000) Cancer Res. 60:2520.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human Collagen IV alpha 1/Arresten Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Collagen IV alpha 1/Arresten Protein, CF and earn rewards!
Have you used Recombinant Human Collagen IV alpha 1/Arresten Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image